Summary
Objective: The possible involvement of reactive oxygen species (ROS) in the protective effects of ischaemic preconditioning (PC) against arrhythmias was examined in anaesthetised dogs using the ROS scavenger N-2-mercaptopropionylglycine (MPG).
Methods: PC was induced in 20 chloralose-urethane anaesthetised dogs by two 5 min occlusions of the left anterior descending (LAD) coronary artery 20 min prior to the prolonged (25 min) ischaemia/reperfusion (I/R) insult. In 10 of these dogs MPG was infused locally into a small side branch of the LAD in a dose of 0.15 mg kg−1 min−1, starting 10 min prior to and continuing throughout the entire PC procedure. In another four dogs subjected to preconditioning in the absence and then 2h later in the presence of MPG free radical formation was evaluated by the chemiluminescence method. Eleven dogs, infused with saline and subjected to a 25 min I/R insult, served as controls. A further 9 dogs, which were not preconditioned, were given MPG over a period of 60 min prior to occlusion.
Results: Preconditioning markedly reduced the number of ventricular premature beats (VPBs; 86 ± 34 v. 377 ± 78; P < 0.05), the episodes of ventricular tachycardia (VT; 2.0 ± 0.7 v. 13.6 ± 4.5; P < 0.05) and the incidences of both VT (60% v. 91%) and ventricular fibrillation (0% v. 82%; P < 0.05) during the prolonged occlusion. Survival (from the combined ischaemia and reperfusion insult) was significantly increased (40% v. 0%; P < 0.05) by PC. MPG did not modify the protective effects of PC, although free radical (mostly superoxide) formation that occurred following PC was abrogated in the presence of MPG. Thus, the number of VPBs (111 ± 39), VT episodes (1.2 ± 0.9) and the incidences of VT (20%) and VF (0%) during occlusion were similar to the PC dogs. MPG itself did not significantly modify arrhythmia severity in non-PC dogs.
Conclusions: We conclude that in our canine model of ischaemia/reperfusion the generation of ROS does not play a trigger role in the early PC-induced antiarrhythmic protection.
Similar content being viewed by others
References
Sun J-Z, Tang X-L, Park S-W, et al. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious dogs. J Clin Invest 1996;97:562–576.
Kaeffer N, Richard V, Thuillez C. Delayed coronary endothelial protection 24 hours after preconditioning. Role of free radicals. Circulation 1997;96:2311–2316.
Yamashita N, Hoshida S, Taniguchi N, et al. A “Second Window of Protection” occurs 24~h after ischemic preconditioning in the rat heart. J Mol Cell Cardiol1998;30:1181–1189.
Tang X-L, Takano H, Rizvi A, et al. Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol, 2002;282:H281–H291.
Yamashita N, Hoshida S, Otsu K, et al. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med1999;189:1699– 1706.
Pain T, Yang X-M, Critz SD, et al. Opening of mitochondrial K ATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000;87:460–466.
Cohen MV, Yang X-M, Liu GS, et al. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K ATP channels. Circ Res 2001; 89:273–278.
Hoshida S, Yamashita N, Otsu K, Hori M. The importance of manganese superoxide dismutase in delayed preconditioning: Involvement of reactive oxygen species and cytokines. Cardiovasc Res 2002;55:495–505.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation1986;74:1124–1136.
Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994;28:980–986.
Iwamoto T, Miura T, Adachi T, et al. Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit. Circulation 1991;83:1015–1022.
Richard V, Tron C, Thuillez C. Ischaemic preconditioning is not mediated by oxygen derived free radicals in rats. Cardiovasc Res1993;27:2016–2021.
Shirato C, Miura T, Ooiwa H, et al. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. J Mol Cell Cardiol 1989;21:1187– 1193.
Baines CP, Goto M., Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207–216.
Liem DA, van den Doel MA, de Zeeuw S, et al. Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors. Cardiovasc Res 2001;51:701–708.
Liem DA, te Lintel Hekkert M, Mannintveld OC, et al. Myocardium tolerant to an adenosine-dependent ischemic preconditioning stimulus can still be protected by stimuli that employ alternative signaling pathways. Am J Physiol Heart Circ Physiol 2004 in press.
Komori S, Fukimaki S, Ijili H, et al. Inhibitory effect of ischaemic preconditioning on ischemic arrhythmias using a rat coronary artery ligation model. Jpn J Electrocardiol 1990;10:774–782.
Végh Á, Szekeres L, Parratt JR. Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res1990;24:1020–1023.
Végh Á, Komori S, Szekeres L, Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 1992;26:487–495.
Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: Reperfusion-induced arrhythmias. Am J Physiol 1987;253:H1470–1476.
Altuğ S, Demiryürek AT, Kane KA, Kanzik I. Evidence for the involvement of peroxinitrite in ischaemic preconditioning in rat isolated hearts. Br J Pharmacol 2000;130:125–131.
Mitsos SE, Fantone JC, Gallagher KP, et al. Canine myocardial reperfusion injury: Protection by a free radical scavenger, N-2-mercaptopropionyl glicine. J Cardiovasc Pharmacol 1986;8:978–988.
Cai M, Ogawa R. Effects of free radical scavengers, methylprednisolone, and ulinastatin on acute xanthine and xanthine oxidase-induced lung injury in rats. Circ Shock 1994;43:1–78.
Woodward B, Zakaria M. Effect of some free radical scavangers on reperfusion-induced arrhythmias. J Mol Cell Cardiol 1985;17:485–494.
Bernier M, Hearse DJ, Manning S. Reperfusion-induced arrhythmias and oxygen derived free radicals: Studies with ‘anti-free radical‘ interventions and a free radical generating system in the isolated perfused hearts. Circ Res1986;58:331–340.
Wainwright CL, Parratt JR. Failure of allopurinol and a spin trapping agent N-t-butyl-α -phenyl nitrone to modify significantly ischaemia and reperfusion-induced arrhythmias. Br J Pharmacol 1987;91:49–59.
Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988; 22:447–455.
Kaszala K, Végh Á, Papp JG, Parratt JR. Time course of the protection against ischaemia and reperfusion-induced ventricular arrhythmias resulting from brief periods of cardiac pacing. J Mol Cell Cardiol 1996;28:2085–2095.
Gyllenhammar H. Lucigenin chemiluminescence in the assessement of neutrophil superoxide production. J Immun Methods 1987;97:209–213.
Guarnieri C, Georgountzos A, Caldarera I, et al. Polyamines stimulate superoxide production in human neutrophils acivated by N-Met-Leu-Phe but not by phorbol myristate acetate. Biochem Biophys Acta 1987;930:135–139.
Bolli R, Jeroudi MO, Patel BS, et al. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Circ Res 1989;65:607–622.
Connaughton M, Lawson CS, Hearse DJ. Ischaemic preconditioning and arrhythmias induced by ischaemia and reperfusion. In: Marber MS, Yellon DM, eds. Ischaemia, Preconditioning and Adaptation. Oxford: Bios Scientific Publisher, 1996;59–84.
Parratt JR, Végh Á, Kaszala K, Papp JGY. Suppression of life-threatening ventricular arrhythmias by brief periods of ischaemia and by cardiac pacing with particular reference to delayed myocardial protection. In: Marber MS, Yellon DM, Eds. Ischaemia, Preconditioning and Adaptation. Oxford: Bios Scientific Publisher, 1996;85–111.
Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971;43:67–74.
Wit AL, Janse MJ. The Ventricular Arrhythmias of Ischemia and Infarction. Electrophysiological Mechanisms. Mount Kisco, NY: Futura Publishing Company, 1993.
Meesmann W. Early arrhythmias and primary ventricular fibrillation after myocardial ischaemia in relation to preexisting coronary collaterals. In: Parratt JR, ed. Early Arrhythmias Resulting from Myocardial Ischaemia. New York: Oxford University Press, 1982;93–112.
Babai L, Szigeti Zs, Parratt JR, Végh Á. Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: Possible involvement of nitric oxide. Clin Sci 2002;102:435–445.
Végh Á, Papp JGy, Parratt JR. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors. Br J Pharmacol 1994;113:1167–1172.
Végh Á, Szekeres L, Parratt JR. Preconditioning of the ischaemic myocardium; involvement of the L-arginine—nitric oxide pathway. Br J Pharmacol1992;107:648–652.
Yellon DM, Downey JM. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev2003;83:113–1151.
Végh Á, Szekeres L, Parratt JR. Transient ischaemia induced by rapid cardiac pacing results in myocardial preconditioning. Cardiovasc Res 1991;25:1051–1053.
Herzberg RM, Rubio R, Berne RM. Coronary occlusion and embolisation effect on blood flow in adjacent arteries. Am J Physiol 1966;210:169–175.
Khouri EM, Gregg DE, Lowensohn HS. Flow in the major branches of the left coronary artery during experimental coronary insufficiency in the unanaesthetised dog. Circ Res 1968;23:99–109.
Feigl EO. Coronary physiology. Physiol Rev1983;63:1–205.
Végh Á, Szekeres L, Parratt JR. Inhibition of nitric oxide production in anaesthetised dogs fails to modify work-induced increase in coronary blood flow. J Physiol (Lond.) 1992;452:16P.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ágnes, H., Nagy, L., Parratt, J.R. et al. N-2-mercaptopropionylglycine, a Scavanger of Reactive Oxygen Species, does not Modify the Early Antiarrhythmic Effect of Ischaemic Preconditioning in Anaesthetised Dogs. Cardiovasc Drugs Ther 18, 449–459 (2004). https://doi.org/10.1007/s10557-004-6222-2
Issue Date:
DOI: https://doi.org/10.1007/s10557-004-6222-2